Larry Summers will resign from teaching at Harvard during review of Epstein ties, university says

Former U.S. Treasury Secretary Larry Summers will resign from teaching at Harvard University as the campus reviews his ties to the late convicted sex offender Jeffrey Epstein. Summers has been ...

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to ...
MPR News

As ICE expands, an AP review of crimes committed by agents shows how their powers can be abused

In this screengrab made from body camera footage provided by the Othello, Wash., Police Department, police officers arrest U.S. Immigration and Customs Enforcement supervisor Koby Williams in July ...
Associated Press

Takeaways from AP’s review of recent criminal cases against ICE employees and contractors

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. At least two dozen U.S. Immigration and Customs ...
BioSpace

DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY ® (datopotamab deruxtecan-dlnk) has been accepted and granted ...
Associated Press

House lawmaker raises new concerns over FDA’s ultra-fast drug review program

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dr. Marty Makary, commissioner of the Food and ...
BioSpace

DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

Based on results from TROPION-Breast02 showing Daiichi Sankyo and AstraZeneca’s DATROWAY significantly improved overall survival versus chemotherapy in this patient population If approved, DATROWAY ...